Atlanta, GEORGIA4 Active Studies

Interstitial Lung Disease Clinical Trials in Atlanta, GEORGIA

Find 4 actively recruiting interstitial lung disease clinical trials in Atlanta, GEORGIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
600
Enrolling

Recruiting Interstitial Lung Disease Studies in Atlanta

RecruitingAtlanta, GEORGIANCT06588686

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, ei...

270 participants
Vicore Pharma AB
View Study Details
RecruitingAtlanta, GEORGIANCT06672549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesi...

125 participants
Eli Lilly and Company
View Study Details
RecruitingAtlanta, GEORGIANCT05999994

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...

105 participants
Eli Lilly and Company
View Study Details
RecruitingAtlanta, GEORGIANCT04015141

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

The purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core study for seizure frequency in participant...

100 participants
Eisai Inc.
View Study Details

About Interstitial Lung Disease Clinical Trials in Atlanta

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 4 interstitial lung disease clinical trials recruiting participants in Atlanta, GEORGIA. These studies are seeking a combined 600 participants. Research is being sponsored by Vicore Pharma AB, Eli Lilly and Company, Eisai Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Atlanta — FAQ

Are there interstitial lung disease clinical trials in Atlanta?

Yes, there are 4 interstitial lung disease clinical trials currently recruiting in Atlanta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 4 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated March 2, 2026 from ClinicalTrials.gov